News
1h
Zacks Investment Research on MSNCan Wegovy & Ozempic Drive Another Strong Quarter for Novo Nordisk?Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...
3h
Money Talks News on MSN5.3 Million Medicare Users to Benefit From New Drug Price NegotiationsThe next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...
17h
Vancouver Sun on MSNB.C. restricts sales of two more diabetes drugs amid weight-loss demandThe B.C. government is restricting the sales of two more diabetes drugs to people outside Canada amid rising demand for the ...
It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 forms, each caused by distinct biological pathways.
IF you’re on a weight loss jab, you’ll have a suppressed appetite and feel full quickly after eating – the ideal recipe for ...
Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...
British Columbia's Ministry of Health is limiting the sales of two more diabetes drugs in an attempt to curb their off-label ...
Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...
From legal pitfalls to temperature-sensitive drugs, here’s how to travel safely and legally with your medication ...
New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including Sen. Marsha Blackburn.
The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School ...
Most policies still exclude weight-loss medications under general exclusions unless they are part of the treatment of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results